In this methodology guide, the HAS has sought to clarify the aspects associated with the organisational impacts of health technologies by drawing up a map aimed at both defining these impacts and proposing criteria to measure their effects or justify them.

 

The organisational impacts created by a health technology can have a structural role in multiple aspects of the healthcare system and affect different actors: patient, carer, healthcare professional, healthcare facility, service provider, etc.

They are frequently claimed or mentioned in the context of the assessment of a medicinal product, medical devices, or diagnostic and therapeutic procedures; they also represent one of the eligibility criteria for economic assessment. However, this aspect of assessment is still rarely documented.

 

A map to structure the assessment of the organisational impacts of a health technology

Firstly, the map specifies the context of the health technology under assessment with reference to whether a conventional care solution is available or not.

It also helps structure how the organisational impacts of a health technology may be identified according to the different actors concerned with a classification based around three macrocriteria:

  • macrocriterion 1: impacts with a direct effect on the components of the care process;
  • macrocriterion 2: impacts with an effect on the skills and capabilities required of the actors involved to implement the care process;
  • macrocriterion 3: impacts on the general population.

 

For each macrocriterion:

  • choice of criteria corresponding to the most relevant organisational impacts according to the actors concerned;
  • proposal of indicators to describe each criterion selected and identify the data to be provided;
  • examples of health technologies to help the user understand the scope of the impact studied and its characteristics.

The map does not indicate how the organisational impacts of a health technology will be taken into account in each HAS committee (CNEDiMTS, CEESP, CT) and by the HAS Board.

 

Contact Us

Évaluation en santé publique et évaluation en vaccins
All our publications